LIGACHEM BIOSCIENCES revenue breakdown overview

LIGACHEM BIOSCIENCES revenue for the last year amounted to 126.95 B KRW, the most of which — 105.36 B KRW — came from its highest performing source at the moment, New Drug Research and Development, the year earlier bringing 12.80 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought LIGACHEM BIOSCIENCES 125.90 B KRW, and the year before that — 34.15 B KRW.